Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis

American Journal of Veterinary Research

Volumn 63, Issue 12, 2002, Pages 1724-1731

  Lentz, Linnea R ^a,d   Valberg, Stephanie J ^d   Herold, Lee V ^b,c   Onan, Gary W ^c,e   Mickelson, James R ^c   Gallant, Esther M ^c  

^a MEDTRONIC INC   (United States)

^b University of Minnesota ^*  (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Clinical and Population Sciences   (United States)

^e UNIVERSITY OF WISCONSIN RIVER FALLS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM ION; CHLOROCRESOL; FURA 2;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL GROWTH; CONTROLLED STUDY; FLUORESCENCE; HORSE; IMAGING; IN VITRO STUDY; INTERCOSTAL MUSCLE; METABOLIC REGULATION; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE CONTRACTURE; MUSCLE FIBRIL; NONHUMAN; RECURRENT DISEASE; RHABDOMYOLYSIS; SARCOPLASMIC RETICULUM; SATELLITE CELL;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0036911015     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1724     Document Type: Article

References (36)

1. MacLeay JM, Sorurn SA, Valberg SJ, et al. Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 1999;60:1562-1566.
2. Valberg SJ, Jonsson L, Holgren N, et al. Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J 1993;25:11-16.
3. MacLeay JM, Valberg SJ, Sorum SA, et al. Heritability of recurrent exertional rhabdomyolysis in Thoroughbred racehorses. Am J Vet Res 1999;60:250-256.
4. Lentz LR, Valberg SJ, Balog E, et al. Abnormal regulation of contraction in equine recurrent exertional rhabdomyolysis. Am J Vet Res 1999;60:992-999.
5. Klein L. A review of 50 cases of post-operative myopathy in the horse-intrinsic and management factors affecting risk. Proc Am Assoc Equine Pract 1978;24:89-94.
6. Waldron-Mease E, Klein LV, Rosenberg H, et al. Malignant hyperthermia in a halothane-anesthetized horse. J Am Vet Med Assoc 1981;179:896-898.
7. Fujii J, Otsu K, Zorzato F, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991;253:448-451.
8. McCarthy TV, Quane KA, Lynch PJ. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 2000;15:410-417.
9. Roberts MC, Mickelson JR, Patterson EE, et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology 2001;95:716-725.
10. Wappler F, Fiege M, Steinfath M, et al. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 2001;94:95-100.
11. Mickelson JR, Louis CF. Malignant hyperthermia: excitation-contraction coupling, calcium release channel, and cell calcium regulation defects. Physiol Rev 1996;76:537-593.
12. Fill M, Coronado R, Mickelson JR, et al. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J 1990;50:471-475.
13. Shomer NH, Louis CF, Fill M, et al. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor. Am J Physiol 1993;264:C125-C135.
14. Jurkat-Rott KT, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 2000;23:4-17.
15. Herrmann-Frank A, Richter M, Sarkozi S, et al. 4-chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta 1996;1289:31-40.
16. Westerblad H, Andrade FH, Islam MS. Effects of ryanodine receptor agonist 4-chloro-m-cresol on myoplasmic free calcium concentration and force of contraction in mouse skeletal muscle. Cell Calcium 1998;24:105-115.
17. Herrmann-Frank A, Richter M, Lehmann-Horn F. 4-chlorom-cresol: a specific tool to distinguish between malignant hyper-thermia-susceptible and normal muscle. Biochem Pharmacol 1996;52:149-155.
18. Ording H, Glahn K, Gardi T, et al. 4-chloro-m-cresol-a possible supplementary test for diagnosis of malignant hyperthermia susceptibility. Acta Anaesthesiol Scand 1997;41:967-972.
19. Ward TL, Valberg SJ, Gallant EM, et al. Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis. Am J Vet Res 2000;61:242-247.
20. Mlekoday JA, Mickelson JR, Horton JH, et al. Calcium sensitivity of muscle fibers and myofibrillar ATPase in equine recurrent exertional rhabdomyolysis. Am J Vet Res 2001;62:1647-1652.
21. Lopez JR, Linares N, Cordovez G, et al. Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflügers Arch 1995;430:293-295.
22. 2+ concentration during exertional rhabdomyolysis. Lancet 1995;345:424-425.
23. Poels PJ, Joosten EM, Sengers RC, et al. In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis. J Neurol Sci 1991;105:67-72.
24. Churchill GC, Atkinson MM, Louis CF. Mechanical stimulation initiates cell to cell calcium signaling in ovine lens epithelial cells. J Cell Science 1996;109:355-365.
25. Tsein RY. Fluorescence measurement and photochemical manipulation of cytosolic free calcium. Trends Neurosci 1988;11:419-424.
26. Kabbara AA, Allen DG. The role of calcium stores in fatigue of isolated single muscle fibers from the cane toad. J Physiol (Lond) 1999;519:190-196.
27. Zorzato F, Scutari E, Tegazzin V, et al. Chlorocresol: an activator of ryanodine receptor-mediated calcium release. Mol Pharmacol 1993;44:1192-1201.
28. Jackson MJ, Jones DA, Edwards, RH, eds. Experimental skeletal muscle damage: the nature of the calcium activated degenerative processes. Eur J Clin Invest 1984;14:369-374.
29. Powell JA, Fambrough DM. Electrical properties of normal and dysgenic mouse skeletal muscle in culture. J Cell Physiol 1973;82:21-38.
30. 2+ pools in human skeletal muscle cells. J Physiol (Lond) 2000;525:461-469.
31. Flutcher B, Andrews SB. Characterization of spontaneous and action potential-induced calcium transients in developing myotubes in vitro. Cell Motil Cytoskeleton 1993;25:143-157.
32. Grouselle M, Koenig J, Lascombe ML, et al. Fura-2 imaging of spontaneous and electrically induced oscillations of intracellular free calcium in rat myotubes. Pflügers Arch 1991;418:40-50.
33. Gschwend MH, Rudel R, Brinkmeier H, et al. A transient and a persistent calcium release are induced by chlorocresol in cultivated mouse myotubes. Pflügers Arch 1999;438:101-106.
34. Gallant EM, Goettl VM. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles. Muscle Nerve 1989;12:56-63.
35. Richter R, Schleithoff L, Deufel T, et al. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem 1997;272:5256-5260.
36. Rousseau E, LaDine J, Lui Q, Meissner G, et al. Activation of the calcium release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys 1988;267:75-86.